Bone Marrow-Derived Mesenchymal Stem Cells and <i>γ</i>-Secretase Inhibitor Treatments Suppress Amyloid-<i>β</i>25–35-Induced Cognitive Impairment in Rat Dams and Cortical Degeneration in Offspring

<div>Pathways of MSCs and GSI-953 against the A<i>β</i>25–35-induced Alzheimer’s disease in neonates. The figure was created with BioRender.com.</div>

Stem Cells International

fig16

Figure 16

Figure 16: Bone Marrow-Derived Mesenchymal Stem Cells and <i>γ</i>-Secretase Inhibitor Treatments Suppress Amyloid-<i>β</i>25–35-Induced Cognitive Impairment in Rat Dams and Cortical Degeneration in Offspring 

Figure 16 | Bone Marrow-Derived Mesenchymal Stem Cells and γ-Secretase Inhibitor Treatments Suppress Amyloid-β25–35-Induced Cognitive Impairment in Rat Dams and Cortical Degeneration in Offspring 